Survivorship research established investigator award

生存研究设立研究者奖

• 批准号: 7629717
• 负责人: CHARLES L LOPRINZI
• 金额: $ 15.61万
• 依托单位: MAYO CLINIC ROCHESTER
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-06-01 至 2013-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7629717
• 关键词: Area; Award; Back; Cancer Control; Cancer Etiology; Chemoprevention; Clinic; Clinical Investigator; Clinical Research; Community Clinical Oncology Program; Complementary and alternative medicine; Comprehensive Cancer Center; Conduct Clinical Trials; Development; Fruit; Funding; Grant; Individual; Inservice Training; Investigation; Leadership; Malignant Neoplasms; Manuscripts; Mentors; Mentorship; North Central Cancer Treatment Group; Patient Care; Persons; Principal Investigator; Process; Protocols documentation; Publishing; Reporting; Research; Research Personnel; Research Scientist Award; Role; Running; Symptoms; Time; abstracting; base; cancer prevention; cancer therapy; career; design; experience; improved; interest; next generation; oncology; programs; response; survivorship

DESCRIPTION (provided by applicant): The specific aim of this grant is to mentor young clinical investigators, primarily in the area of research related to the control of symptoms caused by cancer and/or cancer therapy. A time comes in an investigator's career when a previously mentored person becomes the mentor. Although it might not be easy to admit, being more than half way through my career, I have made the transformation from primarily being mentored, to being a mentor. I am currently the Director of the Cancer Control Program of the North Central Cancer Treatment Group (NCCTG) as well as the co-director of the Cancer Prevention and Control Program of the Mayo Clinic Comprehensive Cancer Center. I have been the Principal Investigator of a community clinical oncology program (CCOP) research base grant for over a decade and have received R01 grant funding in the past. Through this effort, I have, arguably, developed the most productive program in the world designed to evaluate means of alleviating symptoms caused by cancer and/or cancer therapy. Using this background, with the funds obtained from this grant I will provide mentorship for young clinical investigators interested in a career in clinical research related to relief of symptoms from cancer and/or cancer therapy. I will use an "on-the-job" training approach to help them with the development of applicable protocols. I will mentor them through the protocol review process, through the conduct of clinical trials, and through the process to report results as scientific abstracts and manuscripts. I will facilitate their leadership of subsections of the Mayo Oncology Symptom Control Program. I will facilitate their development of independent grant funding. I view this as a process of succession planning, expecting that one or more of these mentored individuals will eventually take my place and continue to promulgate the symptom control research program that we have at Mayo Clinic, allowing them to mentor the next generation of investigators. This role as a mentor allows me to give back to the scientific field some of the fruits from the mentoring that was provided to me in my early career. This should allow for continued investigation for promising means for alleviating symptoms related to cancer and/or cancer therapy. This will improve the care of patients with cancer.

描述（由申请人提供）：该赠款的具体目的是指导年轻的临床研究者，主要是在与癌症和/或癌症治疗引起的症状控制有关的研究领域。在调查员的职业生涯中，一个以前的指导者成为导师。尽管承认这可能并不容易，在我的职业生涯中超过一半，但我已经从主要的指导到成为导师的转变。我目前是北中央癌症治疗组（NCCTG）癌症控制计划的主任，也是梅奥诊所综合癌症中心癌症预防和控制计划的联合指导。我一直是社区临床肿瘤计划（CCOP）研究基础赠款的主要研究者，过去已经获得了R01赠款资金。通过这项努力，我可以说是制定了世界上最有生产力的计划，旨在评估减轻癌症和/或癌症治疗引起的症状的手段。利用这种背景，在这笔赠款中获得的资金，我将为对临床研究生涯感兴趣的年轻临床研究人员提供指导，这与减轻癌症和/或癌症治疗的症状有关。我将使用“在职”培训方法来帮助他们制定适用的协议。我将通过协议审查过程，通过临床试验进行指导，并通过将结果报告为科学摘要和手稿的过程。我将促进他们对梅奥肿瘤症状控制计划的小节领导。我将促进他们发展独立的赠款资金。我认为这是一个继任计划的过程，期望这些有指导者中的一个或多个将最终取代我，并继续颁布我们在Mayo诊所拥有的症状控制研究计划，从而使他们能够指导下一代研究人员。作为导师的这个角色使我能够回馈科学领域的一些成果，这些果实在我的早期职业生涯中提供给了我。这应该允许继续调查，以减轻与癌症和/或癌症治疗相关的症状的有希望的手段。这将改善癌症患者的护理。